Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 861 of 1,261

  1. US 8491893

    Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications

    Quantum Immunologics, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  2. US 8492488

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  3. US 8491884

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  4. US 8492430

    Fused cyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  5. US 8492407

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  6. US 8491890

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  7. US 8492454

    Removable color layer for artificial nail coatings and methods therefore

    Creative Nail Design Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  8. US 8492405

    Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity

    Takeda Pharmaceutical Company Limited · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  9. US 8492403

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  10. US 8492345

    Cyclic peptide antitumor agents

    Northwestern University · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  11. US 8492397

    Aminopyridine derivatives having Aurora A selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  12. US 8492546

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  13. US 8492378

    GSK-3β inhibitor

    Takeda Pharmaceutical Company Limited · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  14. US 8491880

    Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates

    Mersana Therapeutics, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  15. US 8492340

    Methods of treating depression and other related diseases

    Northwestern University · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  16. US 8492373

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  17. US 8491883

    Treatment of amyotrophic lateral sclerosis using umbilical derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  18. US 8492347

    Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus

    The Regents of the University of California · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  19. US 8491886

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  20. US 8492337

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  21. US 8486989

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  22. US 8486433

    Antibacterial deodorant

    JGC Catalysts and Chemicals Ltd. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  23. US 8486391

    Cancer treatment kits using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  24. US 8486965

    Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer

    Takeda Pharmaceutical Company Limited · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.